Delivery Order SPE2DR25D2101-SPE2DR26F46NL
- Not listed
- The Defense Logistics Agency awarded a $14,837.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for Orencia ClickJect 125 mg/mL with a ceiling value of $33,116.56 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $3,594.03 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price contract represents a non-competitive delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,664.23 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on November 3, 2025, with ultimate completion on November 4, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,486.45 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,865.87 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $9,995.21 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,698.20 for Orencia ClickJect 125 mg/ml on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical procurement under the company's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which involved no set-aside designation, represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46NLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,575.14 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on December 16, 2025, with an ultimate completion date of December 17, 2025. This delivery order utilizes firm fixed price contract terms and is not associated with a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. Orencia Clickject is a specialty biologic medication used for treating rheumatoid arthritis and other autoimmune conditions, reflecting the contractor's role in providing specialized therapeutic medications to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 12/15/25 |